© Drug Hunter Inc. 2018-2023
Home > “peptide 78”
potent macrocyclic PCSK9 PPI inhibitor
1000x optimization of biochem. activity
from mRNA display screen and SBDD
J. Med. Chem., 2020, Nov. 10, 2020
Merck, PA + NJ / UCB Ra Pharma, MA
Merck/UCB/Ra Pharma macrocyclic PCSK9 protein-protein interaction (PPI) inhibitor
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
Molecules of the Month
Molecule of the Year